| VITEK 2 Compact |
|
 |
An Introduction
- VITEK 2 Compact is a sophisticated state of art automated microbial identification and susceptibility testing systems.
- It is powered by the Advanced Expert System (AES) software, which validates and interprets susceptibility test results, and detects antibiotic resistance mechanisms.
- VITEK 2 Compact provides timely, relevant information for targeted antibiotic therapy, resulting in improved patient care and lower healthcare expenses. Beneficiaries of this system are microbiologist, the clinician and ultimately, the patient.
- In addition to optimized result reliability, the microbiologist can be confident of detecting antibiotic resistance and even weakly expressed resistance mechanisms.
- This report helps the clinician to make the correct diagnosis and, when necessary, adapt the antibiotic therapy at the earliest possible stage.
- The patient benefits from timely treatment with the most relevant antibiotics.
- This expert software is capable of identifying antibiotic resistance mechanisms, even emerging and low-level resistance.
- It also contributes to the detection of nosocomial infections, enabling proactive measures to be implemented.
Antimicrobial Resistance and Nosocomial Infections
- Following the widespread availability of newly discovered antibiotics in the 1940s, the number of illnesses and deaths from infectious diseases fell dramatically.
- However, bacteria have since been able to develop resistance to existing antibiotic treatments. The development of "multi-resistant" bacteria (such as Staphylococcus aureus and Enterococci), which can be resistant to even second or third generation antibiotics, represents an important healthcare challenge.
- Antimicrobial resistance often concerns nosocomial infections, which are now a leading cause of death in some countries, with up to 60 % of hospital infections caused by multi-resistant microbes.
- In the US, it is estimated that 14,000 patients die every year from hospital-acquired antibiotic -resistant bacteria. The number may be many times more in India.
- Antimicrobial resistance also significantly impacts healthcare expenditure, since the treatment of resistant bacteria requires prolonged hospital stays and often patient isolation.
|
BacT Alert 3D
from bioMerieux France |
|
 |
BacT Alert 3D is capable of reporting
- Rapid Blood Culture (Pyogenic) within 9-24 hours
- Rapid Mycobacterium Culture within 9-14 days
- Mycobacterium Sensitivity within 9-14 days
|
|
